APA (7th ed.) Citation

M, P., V, J., & E, K. (2024). Adverse drug events in cost-effectiveness models of pharmacological interventions for diabetes, diabetic retinopathy, and diabetic macular edema: A scoping review. JBI evidence synthesis, 22(11), 2194. https://doi.org/10.11124/JBIES-23-00511

Chicago Style (17th ed.) Citation

M, Pesonen, Jylhä V, and Kankaanpää E. "Adverse Drug Events in Cost-effectiveness Models of Pharmacological Interventions for Diabetes, Diabetic Retinopathy, and Diabetic Macular Edema: A Scoping Review." JBI Evidence Synthesis 22, no. 11 (2024): 2194. https://doi.org/10.11124/JBIES-23-00511.

MLA (9th ed.) Citation

M, Pesonen, et al. "Adverse Drug Events in Cost-effectiveness Models of Pharmacological Interventions for Diabetes, Diabetic Retinopathy, and Diabetic Macular Edema: A Scoping Review." JBI Evidence Synthesis, vol. 22, no. 11, 2024, p. 2194, https://doi.org/10.11124/JBIES-23-00511.